Heartsciences Inc Quick Ratio (HSCS) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Heartsciences Inc   (NASDAQ: HSCS)

Heartsciences Inc 's Quick Ratio

HSCS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 0.34 below Heartsciences Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 173 other companies have achieved higher Quick Ratio than Heartsciences Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 0 to 3362.

Explain Quick Ratio?
How much Cash & cash equivalents HSCS´s has?
What are HSCS´s Current Liabilities?




HSCS Quick Ratio (Jun 30 2026)
Q1
(Apr 30 2026)
Q4
(Jan 31 2026)
Q3
(Oct 31 2025)
Q2
(Jul 31 2025)
Q1
Y / Y Current Liabilities Change 61.26 % 31.27 % 111.39 % -52.57 % 123.02 %
Y / Y Cash & cash equivalent Change -40.66 % 50.88 % -81.09 % -51.85 % -35.66 %
Quick Ratio MRQ 0.34 0.34 0.3 1.25 0.93
HSCS's Total Ranking # 3362 # 0 # 1919 # 0 # 1510
Seq. Current Liabilities Change 0 % 31.27 % 136.41 % -48.04 % -18.6 %
Seq. Cash & cash equivalent Change 0 % 50.88 % -43.72 % -30.12 % 154.28 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 174
Healthcare Sector # 862
Overall Market # 3362


Quick Ratio Statistics
High Average Low
3.32 1.26 0.03
(Jan 31 2025)   (Oct 31 2023)




Financial Statements
Heartsciences Inc 's Current Liabilities $ 5 Millions Visit HSCS's Balance sheet
Heartsciences Inc 's Cash & cash equivalent $ 2 Millions Visit HSCS's Balance sheet
Source of HSCS's Sales Visit HSCS's Sales by Geography


Cumulative Heartsciences Inc 's Quick Ratio

HSCS's Quick Ratio for the trailling 12 Months

HSCS Quick Ratio

(Jun 30 2026)
12 Months
(Apr 30 2026)
12 Months
(Jan 31 2026)
12 Months
(Oct 31 2025)
12 Months
(Jul 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth 27.35 % 30.03 % 46.94 % 22.25 % 41.09 %
Y / Y Cash & cash equivalent TTM Growth -53.73 % -50.98 % -65.31 % -26.55 % 15.47 %
Quick Ratio TTM 0.42 0.57 0.58 1.16 1.17
Total Ranking TTM # 4745 # 0 # 3000 # 0 # 3227
Seq. Current Liabilities TTM Growth 14.05 % 9.66 % 19.44 % -14.75 % 16.45 %
Seq. Cash & cash equivalent TTM Growth -15.14 % 8.05 % -40.43 % -15.28 % -10.12 %


On the trailing twelve months basis Due to unchanged in Current Liabilities in the Q2 2026 to $4.86 millions, cumulative Quick Ratio decreased to 0.42 below the Heartsciences Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 220 other companies have achieved higher Quick Ratio than Heartsciences Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2026 from 0 to 4745.

Explain Quick Ratio?
How much Cash & cash equivalents HSCS´s has?
What are HSCS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 221
Healthcare Sector # 1004
Within the Market # 4745


trailing twelve months Quick Ratio Statistics
High Average Low
2.62 1.26 0.46
(Oct 31 2024)   (Oct 31 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Neuronetics Inc   0.88 $ 24.947  Millions$ 28.309  Millions
Orthopediatrics Corp  0.87 $ 45.879  Millions$ 52.852  Millions
Haemonetics Corporation  0.85 $ 223.384  Millions$ 263.235  Millions
Lifeward ltd   0.85 $ 9.448  Millions$ 11.159  Millions
Qhslab Inc   0.84 $ 0.317  Millions$ 0.376  Millions
Intelligent Bio Solutions Inc   0.84 $ 4.141  Millions$ 4.935  Millions
Integra Lifesciences Holdings Corp  0.83 $ 274.084  Millions$ 330.881  Millions
Lifestance Health Group Inc   0.82 $ 225.943  Millions$ 274.753  Millions
Pro dex Inc   0.81 $ 10.542  Millions$ 13.086  Millions
Carlisle Companies Incorporated  0.75 $ 665.300  Millions$ 888.400  Millions
Northview Acquisition Corp  0.73 $ 12.200  Millions$ 16.622  Millions
Livanova Plc  0.73 $ 516.619  Millions$ 707.004  Millions
Angiodynamics Inc   0.72 $ 53.864  Millions$ 74.717  Millions
Rosecliff Acquisition Corp I  0.70 $ 14.000  Millions$ 19.869  Millions
Innovage Holding Corp   0.69 $ 141.326  Millions$ 203.891  Millions
Msa Safety Inc  0.69 $ 200.057  Millions$ 288.899  Millions
Valion Bio Inc   0.69 $ 2.108  Millions$ 3.046  Millions
Lensar Inc   0.69 $ 13.565  Millions$ 19.640  Millions
West Pharmaceutical Services Inc   0.68 $ 435.800  Millions$ 640.500  Millions
Nexalin Technology Inc   0.68 $ 1.005  Millions$ 1.485  Millions
Orthofix Medical Inc   0.66 $ 103.810  Millions$ 157.010  Millions
Privia Health Group Inc   0.65 $ 412.200  Millions$ 634.444  Millions
Positron Corporation  0.60 $ 1.357  Millions$ 2.252  Millions
Baxter International Inc   0.60 $ 2,151.000  Millions$ 3,591.000  Millions
Edap Tms Sa  0.58 $ 21.542  Millions$ 36.849  Millions
Invo Fertility Inc   0.57 $ 3.733  Millions$ 6.520  Millions
Align Technology inc   0.55 $ 1,102.591  Millions$ 1,999.055  Millions
Interpace Biosciences Inc   0.54 $ 2.688  Millions$ 4.951  Millions
FAMILY OFFICE OF AMERICA, INC.  0.53 $ 0.637  Millions$ 1.208  Millions
Stryker Corp  0.52 $ 3,507.000  Millions$ 6,684.000  Millions

Date modified: 2026-09-15T11:54:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.